Astera Labs' Post-Earnings Pullback May Be Last Chance to Buy Below $360

Astera Labs' Post-Earnings Pullback May Be Last Chance to Buy Below $360 →

Astera Labs beat Q2 estimates with 104.5% revenue growth and raised guidance, driven by its Scorpio product ramp, though shares pulled back despite analysts' rising price targets.